7 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18646220 | CRYSTALLINE FORMS OF (S)-5-BENZYL-N-(5-METHYL-4-OXO-2,3,4,5-TETRAHYDROPYRIDO [3,2-B][1,4]OXAZEPIN-3-YL)-4H-1,2,4-TRIAZOLE-3-CARBOXAMIDE | COLEMAN, BRENDA LIBBY | 1624 | Non-Final OA | Apr 25, 2024 |
| 18701573 | MICROGLIAL CELL MORPHOMETRY | LIU, XIAO | 2664 | Non-Final OA | Apr 15, 2024 |
| 18248818 | METHODS FOR TREATING AND MONITORING FRONTOTEMPORAL DEMENTIA | COLENA, TRACY CHING-TIAN | 1797 | Non-Final OA | Apr 12, 2023 |
| 17819182 | ENGINEERED ANTI-HER2 BISPECIFIC PROTEINS | ALLEN, MICHAEL D | 1671 | Non-Final OA | Aug 11, 2022 |
| 17797644 | METHODS FOR THE TREATMENT OF HUNTER SYNDROME | CHANDRA, GYAN | 1674 | Non-Final OA | Aug 04, 2022 |
| 17296506 | METHODS FOR TREATING DYSREGULATED LIPID METABOLISM | AEDER, SEAN E | 1642 | Non-Final OA | May 24, 2021 |
| 17178595 | ANTI-HER2 POLYPEPTIDES AND METHODS OF USE THEREOF | SHUPE, ELIZABETH A | 1643 | Final Rejection | Feb 18, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial